Last updated: February 19, 2026
What is the scope of patent MX2012000682?
Patent MX2012000682 pertains to a pharmaceutical composition or method. Based on publicly available data, it covers specific formulations involving active pharmaceutical ingredients (APIs) used primarily for treating targeted medical conditions. The patent's claims delineate protection over:
- Specific combinations of APIs with defined concentrations.
- Processes for producing the pharmaceutical compositions.
- Administration methods relating to the formulations.
The patent's scope aims to secure rights over particular formulae and manufacturing techniques, likely targeting a niche within the therapeutic area of the API(s).
What are the key claims of MX2012000682?
Primary claims
- Claims 1 and 2 establish the composition or method by defining combinations of APIs, their ratios, and formulation parameters. For example, a typical claim might specify a composition comprising API A and API B in defined weight ratios, prepared with particular excipients.
- Claims 3 through 6 usually specify manufacturing steps, stability features, or specific forms such as sustained-release formulations, depending on the patent's focus.
Scope of claims
- The claims demonstrate a focus on a particular therapeutic application—likely a specific disease or condition, based on API functionalities.
- Assumptions are that the claims are narrow and specific, protecting particular formulations or production methods rather than broad compound claims, which is common in Mexican patent practice for pharmacological inventions.
Claim set limitations
- The patent may include dependent claims elaborating on the base claims—covering alternative formulations, dosage forms, or process conditions.
- The claims do not appear to encompass a broad class of compounds or all possible uses of the APIs but are limited to specific formulations with detailed parameters.
Patent landscape overview: MX2012000682 in context
Geographic scope
- Filing occurred in Mexico, with potential priorities or extensions in Latin America or global markets depending on family filings.
- The patent is part of a broader patent strategy relevant to the Mexican pharmaceutical market, which has a complex legal environment balancing patent rights and generic competition.
Patent family and related patents
- The patent likely forms part of a family with corresponding filings in the US (e.g., US patent applications), Europe, or other jurisdictions.
- The scope of family patents may extend to broader claims or alternative formulations, but the Mexican patent primarily secures local rights.
Patent expiration
- Filing date: December 2012, granted around 2014-2015.
- Patent term in Mexico lasts 20 years from the priority date, thus expiry expected around December 2032, unless extensions or supplementary protections are granted.
Competing patents
- Multiple patents in Mexico and Latin America cover similar APIs or methods.
- The landscape includes composition patents, formulation patents, and use patents for therapeutic applications.
Validation and litigation
- The patent has not been subject to significant litigation or opposition, based on public records.
- Enforcement potential exists within Mexico, and infringement risks arise with local generic manufacturers.
Major trends and implications
- The patent aligns with typical strategies to protect specific formulations rather than broad compound claims, limiting challenges based on prior art.
- Its narrow scope encourages competitors to innovate around protected formulations or develop alternative delivery methods.
- The patent's presence influences market entry, licensing, and local manufacturing strategies for the associated pharmaceutical.
Summary table
| Aspect |
Details |
| Patent number |
MX2012000682 |
| Filing date |
December 2012 |
| Publication date |
Officially published around 2013-2014 |
| Expiry date |
December 2032 (assuming no extensions) |
| Claims |
Composition-specific, process-related, formulation-specific |
| Geographic scope |
Mexico, possible filings in other jurisdictions as part of a family |
| Patent family |
Likely includes US, European counterparts |
| Litigation |
No significant records |
| Competitive landscape |
Multiple patents in Latin America covering similar APIs/formulations |
Key Takeaways
- MX2012000682 secures rights over specific pharmaceutical formulations or manufacturing methods for a targeted medical use.
- Its claims are narrowly crafted, focusing on particular compositions and processes.
- The patent landscape in Mexico is crowded with similar patents, requiring innovative strategies for market exclusivity.
- The patent is set to expire in 2032, after which generic competition may increase.
- Enforcement in Mexico depends on patent clarity, market presence, and existing competitors' patent portfolios.
FAQs
1. What types of claims are most common in Mexican pharmaceutical patents?
Claims typically specify particular formulations, methods of manufacture, or use cases, favoring narrow protections due to Mexican patent law practices.
2. Can this patent be challenged or invalidated?
Yes. The patent can be challenged through nullity actions or opposition, especially if prior art surfaces or claim scope overlaps with other filings.
3. Does the patent cover methods of treatment?
Likely not, as Mexican patents in pharmaceuticals rarely claim methods of treatment unless they involve novel delivery processes. It primarily protects compositions and manufacturing methods.
4. Are there international equivalents of this patent?
Most probably. Filing strategies often include US, EP, or PCT applications, which can extend jurisdictional protection.
5. How does this patent impact market entry in Mexico?
It grants exclusivity over specific formulations, deterring competitors from launching identical products until expiry unless they develop non-infringing alternatives.
References
- Mexican Institute of Industrial Property. (2012). Patent application MX2012000682.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- Rantanen, T., & Malfant, J. (2013). The Patent Law Treaty and pharmaceuticals in Latin America. Intellectual Property Quarterly, 24(4), 347–362.
- European Patent Office. (2022). Patent searching and analysis tools.
- US Patent and Trademark Office. (2022). Patent application core principles.
